DRUG TRANSPORT IN THE LIVER - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 390

7. Li L, Meier PJ, Ballatori N. 2000. Oatp2 mediates bidirectional organic solute transport:
a role for intracellular glutathione. Mol Pharmacol 58(2):335-340.
8. Mikkaichi T, Suzuki T, Tanemoto M, Ito S, Abe T. 2004. The organic anion transporter
(OATP) family. Drug Metab Pharmacokinet 19(3):171-179.
9. Campbell SD, de Morais SM, Xu JJ. 2004. Inhibition of human organic anion transporting
polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia. Chem Biol
Interact 150(2):179-187.
10. Sun W, Wu RR, van Poelje PD, Erion MD. 2001. Isolation of a family of organic anion
transporters from human liver and kidney. Biochem Biophys Res Commun 283(2):417-
422.
11. Kobayashi Y, Ohshiro N, Sakai R, Ohbayashi M, Kohyama N, Yamamoto T. 2005. Trans-
port mechanism and substrate specificity of human organic anion transporter 2 (hOat2
[SLC22A7]). J Pharm Pharmacol 57(5):573-578.
12. Khamdang S, Takeda M, Noshiro R, Narikawa S, Enomoto A, Anzai N, Piyachaturawat
P, Endou H. 2002. Interactions of human organic anion transporters and human organic
cation transporters with nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther
303(2):534-539.
13. Sekine T, Cha SH, Tsuda M, Apiwattanakul N, Nakajima N, Kanai Y, Endou H. 1998.
Identification of multispecific organic anion transporter 2 expressed predominantly in the
liver. FEBS Lett 429(2):179-182.
14. Enomoto A, Takeda M, Shimoda M, Narikawa S, Kobayashi Y, Kobayashi Y, Yamamoto
T, Sekine T, Cha SH, Niwa T, Endou H. 2002. Interaction of human organic anion trans-
porters 2 and 4 with organic anion transport inhibitors. J Pharmacol Exp Ther 301(3):797-
802.
15. Kojima R, Sekine T, Kawachi M, Cha SH, Suzuki Y, Endou H. 2002. Immunolocalization
of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. J Am
Soc Nephrol 13(4):848-857.
16. Koepsell H, Endou H. 2004. The SLC22 drug transporter family. Pflugers Arch
447(5):666-676.
17. Kimura H, Takeda M, Narikawa S, Enomoto A, Ichida K, Endou H. 2002. Human or-
ganic anion transporters and human organic cation transporters mediate renal transport
of prostaglandins. J Pharmacol Exp Ther 301(1):293-298.
18. Koepsell H, Schmitt BM, Gorboulev V. 2003. Organic cation transporters. Rev Physiol
Biochem Pharmacol 150:36-90.
19. Zhang P, Tian X, Chandra P, Brouwer KL. 2005. Role of glycosylation in trafficking of
Mrp2 in sandwich-cultured rat hepatocytes. Mol Pharmacol 67(4):1334-1341.
20. Juliano RL, Ling V. 1976. A surface glycoprotein modulating drug permeability in Chi-
nese hamster ovary cell mutants. Biochim Biophys Acta 455(1):152-162.
21. Kawabata S, Oka M, Shiozawa K, Tsukamoto K, Nakatomi K, Soda H, Fukuda M, Ikegami
Y, Sugahara K, Yamada Y, et al. 2001. Breast cancer resistance protein directly confers
SN-38 resistance of lung cancer cells. Biochem Biophys Res Commun 280(5):1216-1223.
22. Carrella M, Roda E. 1999. Evolving concepts in the pathophysiology of biliary lipid
secretion. Ital J Gastroenterol Hepatol 31(7):643-648.
23. Smith AJ, van Helvoort A, van Meer G, Szabo K, Welker E, Szakacs G, Varadi A, Sarkadi
B, Borst P. 2000. MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports
several cytotoxic drugs and directly interacts with drugs as judged by interference with
nucleotide trapping. J Biol Chem 275(31):23530-23539.